1.Diagnosis and treatment of peripheral nerve injury in Wenchuan earthquake: a report of 14 cases.
Jia-can SU ; Zhuo-dong LI ; Bao-qing YU ; Lie-hu CAO ; Chun-cai ZHANG
China Journal of Orthopaedics and Traumatology 2008;21(10):739-740
OBJECTIVETo discuss the diagnosis and treatment of peripheral nerve injury in the earthquake.
METHODSFourteen patients with peripheral nerve injury injured in the earthquake were involved the retrospective study. All cases accepted the timely diagnosis and treatment including anastomosis and repair of the nerve and other conservative treatments. Then the therapeutic effects were observed.
RESULTSAll 14 patients got short-term follow-up and attained the improvement in their symptoms of nerve injury.
CONCLUSIONPeripheral nerve injury has a high incidence in the earthquake. Prevention is very important. The timely and effective treatment should be taken according to spot situations and traumatic conditions of casualties in earthquake.
China ; Earthquakes ; Female ; Follow-Up Studies ; Humans ; Male ; Peripheral Nerve Injuries ; Peripheral Nerves ; surgery ; Peripheral Nervous System Diseases ; diagnosis ; prevention & control ; surgery ; therapy ; Retrospective Studies
2.Chinese expert consensus on the diagnosis and treatment of chemotherapy-induced peripheral neuropathy (2022 edition).
Chinese Journal of Oncology 2022;44(9):928-934
Chemotherapy-induced peripheral neuropathy (CIPN) is a serious clinical problem and challenging for oncologists. CIPN is often a persistent adverse consequence of certain chemotherapeutic agents and more cancer survivors will experience CIPN leading to chronic pain and worsening quality of life. However, the available and effective strategies for clinical treatment of CIPN are very limited. Oncologists are frequently obliged to decrease or stop neurotoxic anticancer drugs, with a possible deleterious impact on the oncological prognostic. The challenges faced by CIPN include further study on the pathological mechanism, dose threshold, incidence, risk factors and clinical characteristics of CIPN; lack of diagnostic criteria and tools of CIPN; lack of effective and standardized CIPN prevention and treatment programs. The current update of research results on these challenging issues of CIPN will provide more decision-making evidence for oncologists to diagnose and treat CIPN. Therefore, Committee of Neoplastic Supportive-Care of China Anti-Cancer Association and Cancer Clinical Chemotherapy Committee of China Anti-Cancer Association convenes some experts to summarize the recent literatures and discuss to reach the consensus about recommendations for the definition, pathophysiological mechanism, assessment, prevention, and treatment of CIPN.
Antineoplastic Agents/adverse effects*
;
Consensus
;
Humans
;
Neoplasms/drug therapy*
;
Peripheral Nervous System Diseases/prevention & control*
;
Quality of Life
3.Potential application of the Kampo medicine goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy.
Marco CASCELLA ; Maria Rosaria MUZIO
Journal of Integrative Medicine 2017;15(2):77-87
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and severe adverse effects related to cancer treatment. Unfortunately, although several agents and protocols have been proposed, no prophylactic strategies have yet to be proven useful. Therefore, new alternative therapies have been considered for CIPN prevention. Herbal medicine in Japan, called Kampo medicine, is derived from traditional Chinese medicine. Goshajinkigan (GJG) is a Kampo medicine, that is comprised of ten herbs. The aim of this work is to analyse the results of pre-clinical and clinical studies on the potential applications of GJG in CIPN prevention.
Antineoplastic Agents
;
adverse effects
;
Drugs, Chinese Herbal
;
therapeutic use
;
Humans
;
Medicine, Kampo
;
Peripheral Nervous System Diseases
;
chemically induced
;
prevention & control
;
Phytotherapy
4.Study on mechanism of bortezomib inducing peripheral neuropathy and the reversing effect of reduced glutathione.
Hong-tao WANG ; Zhuo-gang LIU ; Wei YANG ; Ai-jun LIAO ; Rong ZHANG ; Bin WU ; Hui-han WANG ; Kun YAO ; Ying-chun LI
Chinese Journal of Hematology 2011;32(2):107-111
OBJECTIVETo study the mechanism of bortezomib inducing peripheral neuropathy and the reversing affection of reduced glutathione.
METHODSFemale Wistar rats were randomly divided into three groups. Group 1, treatment with bortezomib; Group 2, treatment with bortezomib and reduced glutathione; Group 3, saline control group. Drugs were administrated on the 1st, 4th, 7th and 11th day for the three groups. The amorphous of sciatic nerve and dorsal root ganglion (DRG) were observed by electron microscope on 14th and 42nd day. On 14th day, laser confocal microscopy was used to detect reactive oxygen species (ROS) of DRG neuron obtained from the rats by treated with DCFH-DA after primary culture.
RESULTSOn 14th day, morphology of sciatic nerve and DRG changed in both group 1 and 2. On 42nd day, the amorphous became normally in group 1. On 14th day, ROS releasing from DRG neuron was increased obviously in group 1 (P < 0.01), while decreased in both group 2 and 3, and the difference between the latter two groups had no statistical significance (P = 0.210).
CONCLUSIONReleasing ROS to injure mitochondrion and endoplasmic reticulum maybe involved in bortezomib induced peripheral neuropathy. Although reduced glutathione can inhibit ROS release, it has no obviously reversal effect for peripheral neuropathy.
Animals ; Boronic Acids ; adverse effects ; Bortezomib ; Female ; Glutathione ; therapeutic use ; Peripheral Nervous System Diseases ; chemically induced ; metabolism ; prevention & control ; Pyrazines ; adverse effects ; Rats ; Rats, Wistar ; Reactive Oxygen Species ; metabolism
5.Anatomical basis and clinical research of pelvic autonomic nerve preservation with laparoscopic radical resection for rectal cancer.
Yan LIU ; Xiao-ming LU ; Kai-xiong TAO ; Jian-hua MA ; Kai-lin CAI ; Lin-fang WANG ; Yan-feng NIU ; Guo-bin WANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(2):211-214
The clinical effect of laparoscopic rectal cancer curative excision with pelvic autonomic nerve preservation (PANP) was investigated. This study evaluated the frequency of urinary and sexual dysfunction of 149 male patients with middle and low rectal cancer who underwent laparoscopic or open total mesorectal excision with pelvic autonomic nerve preservation (PANP) from March 2011 to March 2013. Eighty-four patients were subjected to laparoscopic surgery, and 65 to open surgery respectively. The patients were followed up for 12 months, interviewed, and administered a standardized questionnaire about postoperative functional outcomes and quality of life. In the laparoscopic group, 13 patients (18.37%) presented transitory postoperative urinary dysfunction, and were medically treated. So did 12 patients (21.82%) in open group. Sexual desire was maintained by 52.86%, un-ability to engage in intercourse by 47.15%, and un-ability to achieve orgasm and ejaculation by 34.29% of the patients in the laparoscopic group. Sexual desire was maintained by 56.36%, un-ability to engage in intercourse by 43.63%, and un-ability to achieve orgasm and ejaculation by 33.73% of the patients in the open group. No significant differences in urinary and sexual dysfunction between the laparoscopic and open rectal resection groups were observed (P>0.05). It was concluded that laparoscopic rectal cancer radical excision with PANP did not aggravate or improve sexual and urinary dysfunction.
Adult
;
Autonomic Nervous System
;
injuries
;
Humans
;
Laparoscopy
;
adverse effects
;
Male
;
Middle Aged
;
Peripheral Nerve Injuries
;
etiology
;
prevention & control
;
Postoperative Complications
;
Rectal Neoplasms
;
surgery
;
Sexual Dysfunction, Physiological
;
etiology
;
Urologic Diseases
;
etiology
6.Clinical study of Jiawei Huangqi Guizhi Wuwu Decoction in preventing and treating peripheral neuro-sensory toxicity caused by oxaliplatin.
Yuan LI ; Hui-juan CUI ; Jin-chang HUANG ; Xiao-qin WU
Chinese journal of integrative medicine 2006;12(1):19-23
OBJECTIVETo evaluate the efficacy of Jiawei Huangqi Guizhi Wuwu Decoction (JHGWD) in treating neuro-sensory toxicity induced by oxaliplatin.
METHODSA randomized controlled self-crossover trial was performed. Thirty-one patients were randomly divided into AB and BA groups. Patients in A cycle belonged to the treated group, who were treated with chemotherapy combined with oxaliplatin plus JHGWD. Patients in B cycle belonged to the control group and were treated with chemotherapy alone. The peripheral neuro-sensory toxicity was observed and analyzed.
RESULTSThe main neurotoxicity was cold-induced paresthesia after the use of oxaliplatin, which included hyperaesthesia, chill, anaesthesia in the extremities, electrified sensation, formication, foreign body sensation and pain that might be exacerbated by exposure to cold. Twenty patients (64.5%) suffered from neuro-sensory toxicity in the treated group and 27 cases (87.1%) in the control group. Symptoms were more serious and lasted longer in the control group than those in the treated group (P < 0.01).
CONCLUSIONJHGWD could prevent and reduce the occurrence and intensity of acute peripheral neuro-sensory toxicity caused by oxaliplatin.
Adult ; Aged ; Antineoplastic Agents ; adverse effects ; therapeutic use ; Cross-Over Studies ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Gastrointestinal Neoplasms ; drug therapy ; Humans ; Male ; Middle Aged ; Organoplatinum Compounds ; adverse effects ; therapeutic use ; Paresthesia ; chemically induced ; drug therapy ; prevention & control ; Peripheral Nervous System Diseases ; chemically induced ; drug therapy ; prevention & control ; Phytotherapy
7.Opportunistic Infections and Malignancies in 173 Patients with HIV Infection.
Kang Won CHOE ; Myoung Don OH ; Sang Won PARK ; Hong Bin KIM ; Ui Seok KIM ; Seong Wook KANG ; Hee Jong CHOI ; Dong Hyeon SHIN
Korean Journal of Infectious Diseases 1998;30(6):507-515
BACKGROUND: The frequency and type of major opportunistic infections (OI' s) in HIV-infected patients are different among various countries. To determine major OI' s in Korea, we analyzed OI' s in HIV-infected patients at an university-affiliated teaching hospital in Korea. METHODS: We reviewed medical records for the HIV-infected patients seen at Seoul National University Hospital from 1985 to April 1998. OI' s were diagnosed according to the definition proposed by CDC (1993). RESULTS: One hundred and seventy three patients were analyzed. Over 70% of the patients were followed for more than 6 months. CD4 + lymphocyte counts at the initial visit ranged 200 to 500/mm 3 in 55% of the patients, and was less than 200/mm 3 in 26%. Tuberculosis was the most frequent OI (25%), followed by candidiasis (21%), herpes zoster (20%), and pneumocystis carinii pneumonia (10%). Kaposi' s sarcoma developed in 3 patients (2%), non-Hodgkin' s lymphoma in 2 (1%). Eleven patients (6%) developed peripheral neuropathy, and 8 patients (5%) had HIV encephalopathy. There was no case of toxoplasmosis. The AIDS defining conditions for the 61 AIDS patients was comprised of 39 (64%) tuberculosis, 6 (10%) esophageal candidiasis, and 6 (10 %) pneumocystis carinii pneumonia. Twenty four patients died; 7 patients died of pneumonia and 4 patients committed suicide. There was no long-term nonprogressor. CONCLUSION: Tuberculosis was the most frequent OI in Korean HIV-infected patients. Candidiasis, herpes zoster, and cytomegalovirus diseases were also common. Compared to those in the United States and European countries, the prevalence of toxoplasmosis and Kaposi' s sarcoma were relatively low. Pneumonia was the major cause of death.
AIDS Dementia Complex
;
Candidiasis
;
Cause of Death
;
Centers for Disease Control and Prevention (U.S.)
;
Cytomegalovirus
;
Herpes Zoster
;
HIV Infections*
;
HIV*
;
Hospitals, Teaching
;
Humans
;
Korea
;
Lymphocyte Count
;
Lymphoma
;
Medical Records
;
Opportunistic Infections*
;
Peripheral Nervous System Diseases
;
Pneumonia
;
Pneumonia, Pneumocystis
;
Prevalence
;
Sarcoma
;
Seoul
;
Suicide
;
Toxoplasmosis
;
Tuberculosis
;
United States